Article Sidebar
Main Article Content
Clinical Features and Prevalence of Osteosarcopenia in Chronic Pancreatitis
Main Article Content
Abstract
Background/Aims: The prevalence of sarcopenia and osteopenia/osteoporosis is increased in chronic pancreatitis (CP). This study aims
to evaluate the prevalence and related factors of osteosarcopenia in CP patients.
Materials and Methods: Eighty-three CP patients were included in this cross-sectional observational study. Sarcopenia was assessed by measuring the surface area of the paravertebral muscles at the third lumbar region. Pancreatic fecal elastase (PFE) tests evaluated exocrine pancreatic insufficiency (EPI), while dual-energy x-ray absorptiometry scans assessed osteopenia/osteoporosis. EORTC PAN26 and a symptom questionnaire were administered, alongside nutritional marker assessments concurrent with PFE.
Results: The prevalence of sarcopenia and osteopenia/osteoporosis was found to be 22.9% (n = 19) and 68.7% (n = 44), respectively. Factors associated with sarcopenia included male gender (OR: 4.9, P = .044), severe EPI (OR: 4.2, P = .043), smoking (OR: 4.6, P = .040), and zinc deficiency (OR: 2.2, P = .029). Severe EPI was significantly associated with osteopenia/osteoporosis (P = .010), diabetes mellitus (P = .001), sarcopenia (P = .016), and zinc deficiency (P = .012). Individuals with osteoporosis had higher PAN26 scores (P = .029). Factors independently associated with osteopenia/osteoporosis included female gender (OR: 7.8, P = .004), severe EPI (OR: 8.1, P = .003), and sarcopenia (OR: 5, P = .037). The prevalence of osteosarcopenia was 19.2%.
Conclusion: Osteosarcopenia is common in CP patients. Smoking, zinc deficiency, EPI, and male gender are strongly associated with sarcopenia. Screening for osteosarcopenia is essential in CP patients to facilitate appropriate interventions.
Cite this article as: Döngelli H, Bengi G, Yarol RC, et al. Clinical features and prevalence of osteosarcopenia in chronic pancreatitis. Turk J Gastroenterol. Published online May 5, 2025. doi 10.5152/tjg.2025.24664.
Article Details
References
1. Kleeff J, Whitcomb DC, Shimosegawa T, et al. Chronic pancreatitis. Nat Rev Dis Primers. 2017;3:17060. [CrossRef]
2. Soytürk M, Bengi G, Oğuz D, et al. Turkish Gastroenterology Association, Pancreas Study Group, chronic pancreatitis committee consensus report. Turk J Gastroenterol. 2020;31(suppl 1):S1-S41. [CrossRef]
3. Masamune A, Kikuta K, Kume K, et al. Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019. J Gastroenterol. 2020;55(11):1062-1071. [CrossRef]
4. Huang Y, Badurdeen DS. Acute pancreatitis review. Turk J Gastroenterol. 2023;34(8):795-801. [CrossRef]
5. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. [CrossRef]
6. Yuan S, Larsson SC. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023;144:155533. [CrossRef]
7. Fasullo M, Omer E, Kaspar M. Sarcopenia in chronic pancreatitis - prevalence, diagnosis, mechanisms and potential therapies. Curr Gastroenterol Rep. 2022;24(4):53-63. [CrossRef]
8. Olesen SS, Büyükuslu A, Køhler M, et al. Sarcopenia associates with increased hospitalization rates and reduced survival in patients with chronic pancreatitis. Pancreatology. 2019;19(2):245-251. [CrossRef]
9. Kempeneers MA, Ahmed Ali U, Issa Y, et al. Natural course and treatment of pancreatic exocrine insufficiency in a nationwide cohort of chronic pancreatitis. Pancreas. 2020;49(2):242-248. [CrossRef]
10. Koh A, Oyende O, Humes DJ, et al. Risk of osteopaenia, osteoporosis and osteoporotic fractures in patients with chronic pancreatitis: a systematic review and meta-analysis. Clin Nutr. 2023;42(7):1086-1094. [CrossRef]
11. Paintin J, Cooper C, Dennison E. Osteosarcopenia. Br J Hosp Med (Lond). 2018;79(5):253-258. [CrossRef]
12. Polito A, Barnaba L, Ciarapica D, et al. Osteosarcopenia: a narrative review on clinical studies. Int J Mol Sci. 2022;23(10):5591. [CrossRef]
13. Seicean A, Tantau M, Badea R, et al. The applicability of radial endoscopic ultrasonography in pancreatic diseases. J Gastrointestin Liver Dis. 2007;16(1):77-83.
14. Paternostro R, Lampichler K, Bardach C, et al. The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis. Liver Int. 2019;39(12):2374-2385. [CrossRef]
15. Vanga RR, Tansel A, Sidiq S, et al. Diagnostic performance of measurement of fecal Elastase-1 in detection of exocrine pancreatic insufficiency: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(8):1220-1228.e4. [CrossRef]
16. Messina C, Maffi G, Vitale JA, et al. Diagnostic imaging of osteoporosis and sarcopenia: a narrative review. Quant Imaging Med Surg. 2018;8(1):86-99. [CrossRef]
17. European Organization For Research And Treatment Of Cancer. EORTC QLQ-PAN26 questionnaire. EORTC Quality of Life Group. Available at: https://qol.eortc.org/questionnaire/qlq-pan26/. Accessed January 3, 2025.
18. Whitcomb DC, North American Pancreatitis Study Group. Pancreatitis: TIGAR-O Version 2 Risk/Etiology Checklist with Topic Reviews, Updates, and use Primers. Clin Transl Gastroenterol. 2019;10(6):e00027. [CrossRef]
19. Olesen SS, Nøjgaard C, Poulsen JL, et al. Chronic pancreatitis is characterized by distinct complication clusters that associate with etiological risk factors. Am J Gastroenterol. 2019;114(4):656-664. [CrossRef]
20. Şişman G, Köroğlu E, Erzin Y, et al. Demographic characteristics of chronic pancreatitis patients in the era of endosonography: experience of a single tertiary referral center in Turkey. Turk J Gastroenterol. 2016;27(3):284-289. [CrossRef]
21. Uno K, Yoshikawa N, Kitami K, et al. The sarcopenia index measured using the lumbar paraspinal muscle is associated with prognosis in endometrial cancer. Jpn J Clin Oncol. 2023;53(10):942-949. [CrossRef]
22. Aslam MA, Ma EB, Huh JY. Pathophysiology of sarcopenia: genetic factors and their interplay with environmental factors. Metabolism. 2023;149:155711. [CrossRef]
23. Shintakuya R, Uemura K, Murakami Y, et al. Sarcopenia is closely associated with pancreatic exocrine insufficiency in patients with pancreatic disease. Pancreatology. 2017;17(1):70-75. [CrossRef]
24. van Dronkelaar C, van Velzen A, Abdelrazek M, et al. Minerals and sarcopenia; the role of calcium, iron, magnesium, phosphorus, potassium, selenium, sodium, and zinc on muscle mass, muscle strength, and physical performance in older adults: a systematic review. J Am Med Dir Assoc. 2018;19(1):6-11.e3. [CrossRef]
25. Chasapis CT, Ntoupa PA, Spiliopoulou CA, et al. Recent aspects of the effects of zinc on human health. Arch Toxicol. 2020;94(5):1443-1460. [CrossRef]
26. de la Iglesia D, Vallejo-Senra N, López-López A, et al. Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: a prospective, longitudinal cohort study. J Gastroenterol Hepatol. 2019;34(1):277-283. [CrossRef]
27. Pan J, Xin L, Wang D, et al. Risk factors for diabetes mellitus in chronic pancreatitis: a cohort of 2,011 patients. Med (Baltim). 2016;95(14):e3251. [CrossRef]
28. Dite P, Bojkova M, Belobradkova J, et al. Chronic pancreatitis and diabetes of exocrine pancreas / Type 3c diabetes mellitus / post-pancreatitis diabetes mellitus. J Gastrointestin Liver Dis. 2022;31(4):371-374. [CrossRef]
29. Barkin JA, Barkin JS. Chronic pancreatitis and bone disease. J Clin Densitom. 2020;23(2):237-243. [CrossRef]
30. Duggan SN, O’Sullivan M, Hamilton S, et al. Patients with chronic pancreatitis are at increased risk for osteoporosis. Pancreas. 2012;41(7):1119-1124. [CrossRef]
31. Stigliano S, Waldthaler A, Martinez-Moneo E, et al. Vitamins D and K as factors associated with osteopathy in Chronic Pancreatitis: a Prospective Multicentre Study (P-BONE Study). Clin Transl Gastroenterol. 2018;9(10):197. [CrossRef]